Fuso Chemical Co., Ltd. TSE:4368
Fuso Chemical : Financial results briefing for the second quarter ended September 30, 2024(for Institutional Investors)
Source: MarketScreener
FY03/2025 2nd Quarter Financial Results
For Period from April 1,2024 to
September 30,2024
November 14, 2024
Prime Market（4368）
Tokyo Stock Exchange, Inc.
© FUSO CHEMICAL CO., LTD.
Table of contents
Ⅰ．Financial Summary Results for 2nd Quarter FY03/2025 (period April 1, 2024 - September 30, 2024)
Ⅱ．Segments Results
- Life Science
- Electronic Materials & Functional Chemicals
Ⅲ．FY03/2025 Outlook
(period April 1, 2024 - March 31, 2025)
Copyright © FUSO CHEMICAL CO., LTD.
1
Ⅰ．FY03/2025 1H Financial Summary
(period April 1, 2024 - September 30, 2024)
Copyright © FUSO CHEMICAL CO., LTD.
2
Consolidated Financial Results for FY03/2025 1H
FY03/2025 | vs FY03/2024 | ||||
（unit：100 millions of yen） | FY03/2024 | YoY | YoY ratio | ||
Net sales | 347.5 | 271.3 | ＋76.2 | ＋28.1% ↗ | |
Operating | 81.4 | 55.8 | ＋25.6 | ＋45.9% ↗ | |
profit | |||||
Ordinary | 79.4 | 62.4 | ＋17.0 | ＋27.3% ↗ | |
profit | |||||
Profit | 56.0 | ||||
attributable to | 42.8 | ＋13.2 | ＋30.8% ↗ | ||
owners of parent | |||||
EBITDA | 118.4 | 83.6 | ＋34.8 | ＋41.6% ↗ | |
Earnings per | ¥159.0 | ¥121.6 | +¥37.4 | ＋30.8% ↗ | |
share | |||||
Budget disclosed in May.2024
Budget | Change | vs budget |
316.0 ＋31.5 ＋10.0%
50.5 ＋30.9 ＋61.3%
51.0 ＋28.4 ＋55.9%
34.5 ＋21.5 ＋62.6%
87.5 ＋30.9 ＋35.4%
¥97.8 | +¥61.2 ＋62.6% |
Budget disclosed in Aug.2024
Budget | Change | vs budget |
340.0 | ＋7.5 | ＋2.2% |
72.0 ＋9.4 ＋13.1%
73.5 | ＋5.9 | ＋8.1% |
50.5 | ＋5.5 | ＋11.1% |
109.0 | ＋9.4 | ＋8.7% |
¥143.2 | +¥15.8 | ＋11.0% |
EBITDA︓achieved a record high for the half-year period.
Copyright © FUSO CHEMICAL CO., LTD.
3
Sales & Profit by segment
versus previous year FY03/2024 1H
FY03/2025 | YoY | |||
(unit:100 millions of yen) | 1H | FY03/2024 | change | Ratio |
1H | ||||
▬Life Science | Net sales | 186.6 | 169.7 | ＋16.9 | ＋10.0% ↗ |
Operating | 27.4 | 32.7 | △5.3 | △16.3% ↘ | |
profit | |||||
▬Electronic Materials | Net sales | 160.8 | 101.5 | ＋59.3 | ＋58.4% ↗ |
& Functional Chemicals | Operating | 65.1 | 33.3 | ＋31.8 | ＋95.7% ↗ |
profit | |||||
(Adjustment) | △11.1 | △10.2 | △0.8 ー | ||
Operating pfofit (consolidated) | 81.4 | 55.8 | ＋25.6 | ＋45.9% ↗ | |
Copyright © FUSO CHEMICAL CO., LTD.
4
FY03/2025 Quarterly Results
（unit：
100 ｍillions of yen）
3/'25 | YonY | 3/'25 | YonY |
１Q | change ratio | ２Q | change ratio |
Net sales | 174.3 | ＋37.8 | ＋27.8% | 173.2 | ＋38.3 | ＋28.4% |
Operating | 39.1 | ＋7.1 | ＋22.4% | 42.3 | ＋18.4 | ＋77.4% |
profit | ||||||
Ordinary | 42.9 | ＋5.6 | ＋15.1% | 36.5 | ＋11.3 | ＋45.2% |
profit | ||||||
Profit | 28.8 | 27.2 | ||||
attributable to | ＋4.3 | ＋17.5% | ＋8.9 | ＋48.6% | ||
owners of parent | ||||||
EBITDA | 57.2 | ＋15.4 | ＋37.1% | 61.1 | ＋19.3 | ＋46.1% |
Earnings per | ¥81.8 | +¥12.1 | ¥77.2 | +¥25.2 | ||
share | ||||||
Copyright © FUSO CHEMICAL CO., LTD.
5
Quarterly Results Trends
(100 millions | ４Q | |
of yen) | ||
３Q | ||
700 ２Q
１Q
600
500
422
400
net sales
684
557 158 589
158
161
172
plan 680
(100 millions
of yen)
４Q
200 ３Q
180 ２Q
160 １Q
140
120
operating profit
189 | |||
42 | plan | ||
150 | |||
135 | |||
47 51 110
110
300
144
159
100 | 96 |
80 | 24 |
28
38
108
200
178
123134
173
60 25
48 26
42
101
40
22
3023
100 | 175 | 174 | ||
128 | 136 | |||
102 | ||||
0 | ||||
3/'21 | 3/'22 | 3/'23 | 3/'24 | 3/'25 |
20 | 33 | 46 | 31 | 39 | |
23 | |||||
0 | |||||
3/'21 | 3/'22 | 3/'23 | 3/'24 | 3/'25 |
Copyright © FUSO CHEMICAL CO., LTD.
6
Net Sales by Segment
(100 millions of yen)
400 | Electronic Materials |
350
Life Science
300
159 | 146 | 160 | ||
250 | ||||
136 | 146 | |||
101 | ||||
200 | ||||
107 | ||||
97 |
150 | 90 |
100
50
0
113 120 144
169 193 184 169 171 186
1H | 2H | 1H | 2H | 1H | 2H | 1H | 2H | 1H | 2H |
3/'21 | 3/'22 | 3/'23 | 3/'24 | 3/'25 |
Copyright © FUSO CHEMICAL CO., LTD.
7
Operating Profit by Segment
100 millions of yen
120 | Electronic Materials | ||||||||
Life Science | |||||||||
Electronic Materials | |||||||||
profit ratio | Adjustment | ||||||||
100 | |||||||||
80 | |||||||||
Life Science | 71 | 62 | |||||||
profit ratio | |||||||||
60 | 65 | 65 | |||||||
50 | 33 | 42 | |||||||
40 | |||||||||
35 | 40 | ||||||||
20 | 28 | 33 | 40 | 32 | 27 | ||||
20 | 23 | ||||||||
17 | 15 | ||||||||
50%
40%
30%
20%
10%
0
△20
△6 △6
1H 2H
3/'21
△6 △8
1H 2H
3/'22
△9 △9
1H 2H
3/'23
△10 △10
1H 2H
3/'24
△11
1H 2H
3/'25
0%
Copyright © FUSO CHEMICAL CO., LTD.
8
Net Profit Analysis FY03/2024 1H
versus FY03/2025 1H
（unit︓100millions of yen）
selling, general | ||||||||
3/'24 1H | net sales | CGS | CGS | and | non‐operating | extraordinary | income taxes | 3/'25 １H |
net profit | (other) | (depreciation) | administrative | profit or loss | profit or loss | net profit | ||
expenses |
Copyright © FUSO CHEMICAL CO., LTD.
9